Ascelia Pharma AB's total assets for Q2 2025 were kr125.33M, an increase of 1.91% from the previous quarter. DE:7ZA total liabilities were kr31.62M for the fiscal quarter, a -51.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.